Aspira Women's Health
Austin, US
Biotech
Founders & leadership
WP
Winfred ParnellDirector
SC
Stefanie CavanaughDirector
CF
Celeste FralickDirector
SM
Sandra MilliganPresident
EO
Ellen O'Connor VosDirector
NS
Nicole SandfordChief Executive Officer and Interim Chief Financial Officer
JH
Jannie HerchukDirector
Reported raises · per SEC filings
Form D private placements$1.5MraisedJun 2026 · 19 investors · Biotechnology
Rule 506(b)$3MraisedSep 2025 · 19 investors · Biotechnology
Rule 506(b)$1.4MraisedMar 2025 · 27 investors · Biotechnology
Rule 506(b)$1.9MraisedJul 2024 · 21 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.